A fragment of vasoactive intestinal peptide, VIP(10–28), is an antagonist of VIP in the colon carcinoma cell line, HT29

This publication has 17 references indexed in Scilit:

• Molecular identification and structural requirement of vasoactive intestinal peptide (VIP) receptors in the human colon adenocarcinoma cell line, HT-29
  Biochemical Journal, 1985
• The rat liver vasoactive intestinal peptide binding site. Molecular characterization by covalent cross-linking and evidence for differences from the intestinal receptor
  Biochemical Journal, 1985
• Effects of HIS1 modifications on the ability of vasoactive intestinal peptide to stimulate adenylate cyclase from rat and human tissues
  Peptides, 1984
• Structural requirements for VIP interaction with specific receptors in human and rat intestinal membranes: Effect of nine partial sequences
  Biochemical and Biophysical Research Communications, 1984
• Synthesis, conformational studies and biological activities of VIP and related fragments
  Peptides, 1984
• Molecular identification of receptors for vasoactive intestinal peptide in rat intestinal epithelium by covalent cross‐linking
  European Journal of Biochemistry, 1984
• Vasoactive intestinal peptide (VIP) control of glycogenolysis in the human colon carcinoma cell line HT‐29 in culture
  FEBS Letters, 1981
• Degradation of vasoactive intestinal polypeptide by tissue homogenates
  Biochemical and Biophysical Research Communications, 1980
• Specificity of receptors to vasoactive intestinal peptide in guinea pig brain
  Life Sciences, 1979
• THE PHARMACOLOGICAL DIFFERENTIATION OF ADRENERGIC RECEPTORS*
  Annals of the New York Academy of Sciences, 1967